China’s lengthy approval process for genetically modified (GM) crops remains a sticking point in talks to end the trade war between China and the United States, said Reuters.
Beijing has taken years to approve new strains of GM crops, which US companies and farmers have complained stalls trade by restricting the sales of new products from companies such as DowDuPont Inc and Moncentra.
GM crops and the approval process are still a “big issue” in the discussions, said a Reuters source. The issue has been a source of tension between the two countries for years, as China is the biggest buyer of US soybeans, the bulk of which are genetically modified.
You must log in to post a comment.